About N-[(3S)-3-[[(2-imidazol-1-ylacetyl)-(2-methylpropyl)amino]-(4-methylpentanoyl)amino]-4-oxo-4-(phenylmethoxyamino)butyl]benzamide
N-[(3S)-3-[[(2-imidazol-1-ylacetyl)-(2-methylpropyl)amino]-(4-methylpentanoyl)amino]-4-oxo-4-(phenylmethoxyamino)butyl]benzamide (PubChem CID 20658012) has the molecular formula C33H44N6O5
and a molecular weight of 604.75 g/mol. Its IUPAC name is N-[(3S)-3-[[(2-imidazol-1-ylacetyl)-(2-methylpropyl)amino]-(4-methylpentanoyl)amino]-4-oxo-4-(phenylmethoxyamino)butyl]benzamide.
Molecular Properties
| Compound Name | N-[(3S)-3-[[(2-imidazol-1-ylacetyl)-(2-methylpropyl)amino]-(4-methylpentanoyl)amino]-4-oxo-4-(phenylmethoxyamino)butyl]benzamide |
| PubChem CID | 20658012 |
| Molecular Formula | C33H44N6O5 |
| Molecular Weight | 604.75 g/mol |
| Exact Mass | 604.34 |
| IUPAC Name | N-[(3S)-3-[[(2-imidazol-1-ylacetyl)-(2-methylpropyl)amino]-(4-methylpentanoyl)amino]-4-oxo-4-(phenylmethoxyamino)butyl]benzamide |
| SMILES | CC(C)CCC(=O)N([C@@H](CCNC(=O)c1ccccc1)C(=O)NOCc1ccccc1)N(CC(C)C)C(=O)Cn1ccnc1 |
| InChI | InChI=1S/C33H44N6O5/c1-25(2)15-16-30(40)39(38(21-26(3)4)31(41)22-37-20-19-34-24-37)29(17-18-35-32(42)28-13-9-6-10-14-28)33(43)36-44-23-27-11-7-5-8-12-27/h5-14,19-20,24-26,29H,15-18,21-23H2,1-4H3,(H,35,42)(H,36,43)/t29-/m0/s1 |
| InChIKey | VNBZQUDZOJZTLY-LJAQVGFWSA-N |
| XLogP | 3.98 |
| TPSA | 125.87 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 604.75 |
| LogP ≤ 5 | 3.98 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Analyze N-[(3S)-3-[[(2-imidazol-1-ylacetyl)-(2-methylpropyl)amino]-(4-methylpentanoyl)amino]-4-oxo-4-(phenylmethoxyamino)butyl]benzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[(3S)-3-[[(2-imidazol-1-ylacetyl)-(2-methylpropyl)amino]-(4-methylpentanoyl)amino]-4-oxo-4-(phenylmethoxyamino)butyl]benzamide?
The IUPAC name of N-[(3S)-3-[[(2-imidazol-1-ylacetyl)-(2-methylpropyl)amino]-(4-methylpentanoyl)amino]-4-oxo-4-(phenylmethoxyamino)butyl]benzamide (CID 20658012) is N-[(3S)-3-[[(2-imidazol-1-ylacetyl)-(2-methylpropyl)amino]-(4-methylpentanoyl)amino]-4-oxo-4-(phenylmethoxyamino)butyl]benzamide.
What is the SMILES notation for N-[(3S)-3-[[(2-imidazol-1-ylacetyl)-(2-methylpropyl)amino]-(4-methylpentanoyl)amino]-4-oxo-4-(phenylmethoxyamino)butyl]benzamide?
The canonical SMILES for N-[(3S)-3-[[(2-imidazol-1-ylacetyl)-(2-methylpropyl)amino]-(4-methylpentanoyl)amino]-4-oxo-4-(phenylmethoxyamino)butyl]benzamide is CC(C)CCC(=O)N([C@@H](CCNC(=O)c1ccccc1)C(=O)NOCc1ccccc1)N(CC(C)C)C(=O)Cn1ccnc1.
What is the InChIKey of N-[(3S)-3-[[(2-imidazol-1-ylacetyl)-(2-methylpropyl)amino]-(4-methylpentanoyl)amino]-4-oxo-4-(phenylmethoxyamino)butyl]benzamide?
The InChIKey is VNBZQUDZOJZTLY-LJAQVGFWSA-N. The full InChI is InChI=1S/C33H44N6O5/c1-25(2)15-16-30(40)39(38(21-26(3)4)31(41)22-37-20-19-34-24-37)29(17-18-35-32(42)28-13-9-6-10-14-28)33(43)36-44-23-27-11-7-5-8-12-27/h5-14,19-20,24-26,29H,15-18,21-23H2,1-4H3,(H,35,42)(H,36,43)/t29-/m0/s1.
What are the key properties of N-[(3S)-3-[[(2-imidazol-1-ylacetyl)-(2-methylpropyl)amino]-(4-methylpentanoyl)amino]-4-oxo-4-(phenylmethoxyamino)butyl]benzamide?
N-[(3S)-3-[[(2-imidazol-1-ylacetyl)-(2-methylpropyl)amino]-(4-methylpentanoyl)amino]-4-oxo-4-(phenylmethoxyamino)butyl]benzamide has a molecular weight of 604.75 g/mol, XLogP of 3.98, 16 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3S)-3-[[(2-imidazol-1-ylacetyl)-(2-methylpropyl)amino]-(4-methylpentanoyl)amino]-4-oxo-4-(phenylmethoxyamino)butyl]benzamide is sourced from PubChem (CID 20658012), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).